Susquehanna International Group
RPTP

Susquehanna International Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Susquehanna International Group’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-209,309
Closed -$1.49M – 9737
2016
Q2 		$1.12M Buy
209,309
+190,518
+1,014% +$977K ﹤0.01% 4639
2016
Q1 		$86K Sell
18,791
-696,956
-97% -$2.8M ﹤0.01% 8497
2015
Q4 		$3.72M Sell
715,747
-477,869
-40% -$2.77M ﹤0.01% 2941
2015
Q3 		$7.22M Buy
1,193,616
+130,161
+12% +$1.6M ﹤0.01% 2195
2015
Q2 		$16.8M Buy
1,063,455
+349,996
+49% +$4.25M 0.01% 1479
2015
Q1 		$7.75M Sell
713,459
-271,978
-28% -$2.78M ﹤0.01% 2162
2014
Q4 		$10.4M Buy
985,437
+315,286
+47% +$3.08M ﹤0.01% 2004
2014
Q3 		$6.43M Sell
670,151
-213,754
-24% -$2.18M ﹤0.01% 2663
2014
Q2 		$10.2M Buy
883,905
+483,229
+121% +$4.4M ﹤0.01% 2102
2014
Q1 		$4.01M Buy
400,676
+242,917
+154% +$3.51M ﹤0.01% 3207
2013
Q4 		$2.05M Buy
157,759
+98,978
+168% +$1.36M ﹤0.01% 4227
2013
Q3 		$878K Buy
58,781
+19,514
+50% +$234K ﹤0.01% 5507
2013
Q2 		$367K Buy
+39,267
New +$266K ﹤0.01% 6498

Susquehanna International Group's RPTP Position: Q3 2016 in Review

Susquehanna International Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 209,309 shares — an estimated $1.49M sold.

Susquehanna International Group first reported a position in RPTP in Q2 2013 and held it in 13 quarters. The position peaked at $16.8M in Q2 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Susquehanna International Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Susquehanna International Group sold 209,309 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $1.49M.
  • Susquehanna International Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • Susquehanna International Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $16.8M in Q2 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.